Drug Discovery & Pharmaceuticals

RSS
Yale chemists synthesize complex anticancer molecules from marine invertebrates

Yale chemists synthesize complex anticancer molecules from marine invertebrates

Selkirk Pharma announces new APS qualified facility with advanced fill/finish capacity in Spokane, WA

Selkirk Pharma announces new APS qualified facility with advanced fill/finish capacity in Spokane, WA

Collaborative project gets $20 million to develop new radiopharmaceutical cancer therapies

Collaborative project gets $20 million to develop new radiopharmaceutical cancer therapies

Scripps Research scientists develop an antibody that blocks lethal snake toxins

Scripps Research scientists develop an antibody that blocks lethal snake toxins

Molecular glue could pave the way for new generation of drugs

Molecular glue could pave the way for new generation of drugs

Cellectricon’s expertise in pain research recognized by second EU research grant

Cellectricon’s expertise in pain research recognized by second EU research grant

Novel synthetic antibiotic effective against drug-resistant bacteria

Novel synthetic antibiotic effective against drug-resistant bacteria

Breaking through new research barriers with iPSC technology

Breaking through new research barriers with iPSC technology

Academia's drug discovery challenges: Exploring the "publication landfill"

Academia's drug discovery challenges: Exploring the "publication landfill"

Hamamatsu introduces the New FDSS-GX: the highest-performance kinetic plate imager in the FDSS series

Hamamatsu introduces the New FDSS-GX: the highest-performance kinetic plate imager in the FDSS series

SCIEX expands high-throughput screening solutions with Echoâ MS+ system

SCIEX expands high-throughput screening solutions with Echoâ MS+ system

Almirall and Microsoft partner on AI-powered drug discovery in dermatology

Almirall and Microsoft partner on AI-powered drug discovery in dermatology

New molecule is one step closer to becoming a treatment for Phelan-McDermid syndrome

New molecule is one step closer to becoming a treatment for Phelan-McDermid syndrome

Researchers discover non-opioid therapeutic for relieving neuropathic pain

Researchers discover non-opioid therapeutic for relieving neuropathic pain

CN Bio appoints Joseph Parisi as US Director of Sales to support accelerated growth in key OOC market

CN Bio appoints Joseph Parisi as US Director of Sales to support accelerated growth in key OOC market

Enterprise Therapeutics closes £26 million ($33.1 million) Series B follow-on financing

Enterprise Therapeutics closes £26 million ($33.1 million) Series B follow-on financing

New DNA-based vaccine can induce strong antibody response against SARS-CoV-2

New DNA-based vaccine can induce strong antibody response against SARS-CoV-2

New study opens unprecedented opportunities for bioengineering vaccine adjuvants

New study opens unprecedented opportunities for bioengineering vaccine adjuvants

CN Bio and Altis Biosystems partner to develop next-generation human Gut/Liver in vitro model for advanced ADME studies

CN Bio and Altis Biosystems partner to develop next-generation human Gut/Liver in vitro model for advanced ADME studies

C-Path's TRxA launches 2024 grants to boost next-gen therapeutics

C-Path's TRxA launches 2024 grants to boost next-gen therapeutics

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.